Astatine-211 based PSMA-inhibitors for targeted alpha-therapy of prostate cancer

被引：0
|
作者：
Poulie, Christian [1 ]
El Fakiri, Mohamed [2 ]
Ayada, Nawal [2 ]
Gamzov, Teodor [1 ]
Muller, Marius [1 ]
Jensen, Holger [3 ]
Lindegren, Sture [4 ]
Jensen, Andreas [1 ,5 ]
Kjaer, Andreas
Eder, Ann-Christin [2 ]
Eder, Matthias [6 ]
Herth, Matthias [1 ]
机构：
[1] Univ Copenhagen, Copenhagen, Denmark
[2] German Canc Res Ctr, Heidelberg, Germany
[3] Copenhagen Univ Hosp, Rigshosp, Copenhagen, Denmark
[4] Univ Gothenburg, Gothenburg, Sweden
[5] Tech Univ Denmark, Lyngby, Denmark
[6] Univ Med Ctr, Freiburg, Germany
来源：
NUCLEAR MEDICINE AND BIOLOGY | 2022年 / 108卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P-017
引用
收藏
页码：S60 / S60
页数：1
相关论文
共 50 条
  • [11] Astatine-211: Endogenous alpha-radiotherapy for thyroid cancer
    Brown, I
    Randle, K
    IMMUNODEFICIENT ANIMALS: MODELS FOR CANCER RESEARCH, 1996, 51 : 161 - 165
  • [12] Pretargeted Alpha Therapy of Disseminated Cancer Combining Click Chemistry and Astatine-211
    Timperanza, Chiara
    Jensen, Holger
    Back, Tom
    Lindegren, Sture
    Aneheim, Emma
    PHARMACEUTICALS, 2023, 16 (04)
  • [13] Targeted radionuclide therapy with astatine-211: Oxidative dehalogenation of astatobenzoate conjugates
    David Teze
    Dumitru-Claudiu Sergentu
    Valentina Kalichuk
    Jacques Barbet
    David Deniaud
    Nicolas Galland
    Rémi Maurice
    Gilles Montavon
    Scientific Reports, 7
  • [14] Targeted radionuclide therapy with astatine-211: Oxidative dehalogenation of astatobenzoate conjugates
    Teze, David
    Sergentu, Dumitru-Claudiu
    Kalichuk, Valentina
    Barbet, Jacques
    Deniaud, David
    Galland, Nicolas
    Maurice, Remi
    Montavon, Gilles
    SCIENTIFIC REPORTS, 2017, 7
  • [15] ASTATINE-211 - ITS POSSIBLE APPLICATIONS IN CANCER-THERAPY
    BROWN, I
    APPLIED RADIATION AND ISOTOPES, 1986, 37 (08) : 789 - &
  • [16] The potential of Astatine-211 for NIS-mediated radionuclide therapy in prostate cancer in vitro and in vivo
    Willhauck, M.
    Somani, B. -R. Sharif
    Wunderlich, N.
    Wolf, I.
    Senekowitsch-Schmidtke, R.
    Meyer, G. J.
    Knapp, W.
    Goeke, B.
    Morris, J. C.
    Spitzweg, C.
    HORMONE RESEARCH, 2007, 68 : 44 - 44
  • [17] Astatine-211 based radionuclide therapy: Current clinical trial landscape
    Albertsson, Per
    Baeck, Tom
    Bergmark, Karin
    Hallqvist, Andreas
    Johansson, Mia
    Aneheim, Emma
    Lindegren, Sture
    Timperanza, Chiara
    Smerud, Knut
    Palm, Stig
    FRONTIERS IN MEDICINE, 2023, 9
  • [18] Development of an X-ray imaging camera for targeted radionuclide therapy with astatine-211
    Kusano, Hiroki
    Kusumoto, Tamon
    Hasegawa, Sumitaka
    Kodaira, Satoshi
    RADIATION MEASUREMENTS, 2024, 177
  • [19] Preclinical evaluation of dual-labeled PSMA-inhibitors for the diagnosis and therapy of prostate cancer
    Baranski, Ann-Christin
    Schaefer, Martin
    Bauder-Wuest, Ulrike
    Roscher, Mareike
    Schmidt, Jana
    Stenau, Esther
    Simpfendoerfer, Tobias
    Maier-Hein, Lena
    Hadaschik, Boris
    Haberkorn, Uwe
    Eder, Matthias
    Kopka, Klaus
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [20] The potential of PSMA-targeted alpha therapy in the management of prostate cancer
    Filippi, Luca
    Chiaravalloti, Agostino
    Schillaci, Orazio
    Bagni, Oreste
    EXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (10) : 823 - 829
12345